Table 2 Mean (95% CI) change in outcomes within groups and among groups (intention-to-treat population) from baseline to 3-months in a randomised trial of an eHealth lifestyle intervention for women with recent GDM.

Weight (kg)

-1.99

(-2.00, -1.97)

-1.93

(-1.97, -1.89)

-1.27

(-1.33, -1.21)

-0.66

(-2.47, 1.14)

-0.72

(-2.41, 0.98)

-0.06

(-1.76, 1.64)

.660

ARFS

(max. 73)^c

-0.89

(-1.37, -0.42)

1.09

(0.53, 1.64)

-0.31

(-1.4, 0.8)

0.41

(-5.06, 5.87)

1.92

(-3.24, 7.08)

-1.92

(-7.08, 3.24)

.73

% energy- core foods^d

6.76

(5.95, 7.57)

6.06

(5.13, 7.00)

7.36

(5.48, 9.24)

0.68

(-7.35, 8.72)

-0.46

(-8.09, 7.16)

0.46

(-7.16, 8.09)

.95

MVPA (minutes/week)

26.77

(23.52, 30.02)

-23.97

(-31.41, -16.52)

64.70

(52.18, 77.21)

-88.66

(-167.73, -9.59)

-37.93

(-113.02, 37.17)

50.73

(-24.34, 125.81)

.08

WEL-SF (max. 80)

9.71

(9.27, 10.15)

-3.59

(-4.60, -2.58)

-1.35

(-2.86, 0.15)

-2.23

(-13.27, 8.80)

11.06

(0.63, 21.49)*

13.29

(2.77, 23.82)*

.03^e

Ex-SE^c

(max. 90)

5.51(5.03, 5.99)

-4.81(-5.86, -3.76)

-4.11 (-5.71, -2.50)

-0.70(-1.26, -0.15)

9.62(8.49, 10.75)

10.32(9.75, 10.90)

.12

AQoL-6D Utility^d

(max 1)

0.07

(0.07, 0.08)

-0.01

(-0.01, 0.00)

-0.01

(-0.02, 0.00)

0.01

(-0.07, 0.09)

0.09

(0.01, 0.16)*

0.08

(0.01, 0.15)*

.03^e